Our first experience with subtreshold diode laser in the treatment of macular edema
Abstract
Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium. Therapy with subtreshold diode micropulse laser was used for treating macular edema as a result of diabetic retinopathy, branch retinal vein occlusion and central serous chorioretinopathy. Before treatment, all patients were examinated by optical coherence tomography (OCT) to measure their retinal thickness and visual acuity. In some patients fluorescein angiography (FA) was also performed before treatment. Patients were monitored on monthly basis by measuring their visual acuity and retinal thickness. Using OCT to measure macular edema, all patients showed a reduced macular edema at their first monthly check-up. These results show that the therapy with subtreshold diode micropulse laser is successful in diminishing macular edema.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
